文献速递血栓与止血

预防性给予HPA-1a特异性抗体可预防小鼠胎儿/新生儿同种免疫性血小板减少症

Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice.
PubMed 文献 · Blood · 2022-01-01

胎儿/新生儿同种免疫性血小板减少症(FNAIT)由母体抗HPA-1a同种抗体引起,目前尚无获批预防疗法。本研究在新型临床前小鼠模型中显示,两种人HPA-1a特异性抗体候选物(多克隆和单克隆)均能快速完全清除循环HPA-1a+血小板并预防HPA-1a同种抗体产生;预防性治疗母鼠所产HPA-1a+/-幼鼠血小板计数显著改善且无出血症状。这些临床前数据确立了HPA-1a特异性抗体预防人类FNAIT的潜力和阈值暴露目标。

要点

  • 两种人HPA-1a特异性抗体(多克隆和单克隆)均快速完全清除循环HPA-1a+血小板。
  • 预防性治疗阻止了HPA-1a同种抗体的产生。
  • 预防性治疗母鼠所产HPA-1a+/-幼鼠血小板计数显著改善且无出血症状。

核心结论

  • 临床前数据确立了HPA-1a特异性抗体预防人类FNAIT的潜力和阈值暴露目标。

研究设计与样本

  • 新型临床前小鼠FNAIT模型,评估两种人HPA-1a特异性治疗候选物(一种多克隆抗体,一种单克隆抗体)预防同种免疫的能力。

主要发现

  • 两种抗体 preparations 均实现HPA-1a+血小板从循环中快速完全清除。
  • 两种抗体 preparations 均预防了HPA-1a同种抗体的产生。
  • 预防性给予抗HPA-1a抗体的HPA-1a-雌鼠所产HPA-1a+/-幼鼠血小板计数显著改善且无出血症状。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fetal/neonatal alloimmune thrombocytopenia (FNAIT) is a life-threatening bleeding disorder caused by maternal alloantibodies directed against paternally inherited human platelet alloantigens (HPAs) present on the surface of fetal and neonatal platelets. There are currently no approved therapies for the prevention of FNAIT. We report herein the ability of 2 human HPA-1a-specific therapeutic candidates, one a polyclonal, and the other a monoclonal antibody, to prevent alloimmunization in a novel preclinical mouse model of FNAIT. Both antibody preparations effected the rapid and complete elimination of HPA-1a+ platelets from circulation and prevented the development of HPA-1a alloantibodies. HPA-1a- female mice treated prophylactically with anti-HPA-1a antibody prior to exposure to HPA-1a+ platelets gave birth to HPA-1a+/- pups with significantly improved platelet counts and no bleeding symptoms. These preclinical data establish both the potential and threshold exposure targets for prophylactic treatment with HPA-1a-specific antibodies for the prevention of FNAIT in humans.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Zhi H, Sheridan D, Newman DK, et al. Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice. Blood. 2022. PMID: 35881848. doi:10.1182/blood.2022015666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。